Clinical Trials Browser

Phase 1/2 × INDUSTRY × senaparib × Clear all

NCT04434482 2024-09-19

IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer

Phase 1/2 Completed

Small Cell Lung Carcinoma